The circular of the ministry: for under 60 ok to the recall with Astrazeneca if the mix is ​​rejected

• Vaccines: in Lazio advance plan for the recall of Az. In Modern Pharmacy

• Campania, De Luca: "Let's all get vaccinated otherwise the recreation ends"

• Ema: vaccine mix could be used, but little data so far

• Vaccines, Son: "Those in mRna will be enough for everyone. Safe and effective mix"

Share

June 19, 2021 Free booster with AstraZeneca for people under 60 who "after receiving the first dose of Vaxzevria vaccine, refuse crossing to mRNA vaccine and declare that they want to continue booster with the same vaccine used for the first dose ". This is certified by the circular from the Ministry of Health following the announcement yesterday evening by Prime Minister Draghi. "As highlighted by the CTS - reads the document signed by the Director General of Prevention Gianni Rezza - without prejudice to the priority indication of second dose with mRNA vaccine, inspired by a principle of maximum caution aimed at preventingonset of VITT phenomena in subjects at low risk of developing serious COVID-19 disease and on a principle of equity that requires to ensure all subjects equal conditions in balancing benefits / risks, if a subject under the age of 60, after having received the first dose of Vaxzevria vaccine, even in the face of documented and accurate information provided by the vaccinator or by the operators of the vaccination center on the risks of VITT, refusals without possibility of conviction, crossing to the mRNA vaccine, to the same, after the acquisition of adequate informed consent, the second dose of Vaxzevria may be given. "even in the face of documented and accurate information provided by the vaccinating physician or by the operators of the vaccination center on the risks of VITT, refusals without possibility of conviction, the crossing to vaccine to mRNA, the same, after acquiring adequate informed consent, can be administered the second dose of Vaxzevria ".even in the face of documented and accurate information provided by the vaccinating physician or by the operators of the vaccination center on the risks of VITT, refusals without possibility of conviction, the crossing to vaccine to mRNA, the same, after acquiring adequate informed consent, can be administered the second dose of Vaxzevria ".

An option, writes the ministry, which "is coherent and balanced by the benefit deriving from the cancellation of the risk associated with the partial protection conferred by the administration of a single dose of Vaxzevria".

"With regard to the requests for clarification relating to the Janssen vaccine, the following is specified: the CTS, with an opinion transmitted with a circular dated 11 June 2021, recommended the Janssen vaccine for subjects over the age of 60, also in light of what is defined by Aifa Scientific Technical Commission ". This was specified by a circular from the Ministry of Health concerning the completion of the vaccination cycle in subjects under 60 who received a first dose of Vaxzevria vaccine and clarifications on how to use the Janssen vaccine (Johnson & Johnson).